Skip to main content

Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity.

Ghazal, A., Clarke, D., Abdel-Rahman, M. A., Ribeiro, A., Collie-Duguid, E., Pattinson, C., Burgoyne, K., Muhammad, T., Alfadhel, S., Heidari, Z., Samir, R., Gerges, M. M., Nkene, I., Colamarino, R. A., Hijazi, K. and Houssen, W. E., 2024. Venomous gland transcriptome and venom proteomic analysis of the scorpion Androctonus amoreuxi reveal new peptides with anti-SARS-CoV-2 activity. Peptides, 173, 171139.

Full text available as:

Venomous gland transcriptome and venom proteomic analysis of the.pdf - Published Version
Available under License Creative Commons Attribution.


DOI: 10.1016/j.peptides.2023.171139


The recent COVID-19 pandemic shows the critical need for novel broad spectrum antiviral agents. Scorpion venoms are known to contain highly bioactive peptides, several of which have demonstrated strong antiviral activity against a range of viruses. We have generated the first annotated reference transcriptome for the Androctonus amoreuxi venom gland and used high performance liquid chromatography, transcriptome mining, circular dichroism and mass spectrometric analysis to purify and characterize twelve previously undescribed venom peptides. Selected peptides were tested for binding to the receptor-binding domain (RBD) of the SARS-CoV-2 spike protein and inhibition of the spike RBD – human angiotensin-converting enzyme 2 (hACE2) interaction using surface plasmon resonance-based assays. Seven peptides showed dose-dependent inhibitory effects, albeit with IC50 in the high micromolar range (117–1202 µM). The most active peptide was synthesized using solid phase peptide synthesis and tested for its antiviral activity against SARS-CoV-2 (Lineage B.1.1.7). On exposure to the synthetic peptide of a human lung cell line infected with replication-competent SARS-CoV-2, we observed an IC50 of 200 nM, which was nearly 600-fold lower than that observed in the RBD – hACE2 binding inhibition assay. Our results show that scorpion venom peptides can inhibit the SARS-CoV-2 replication although unlikely through inhibition of spike RBD – hACE2 interaction as the primary mode of action. Scorpion venom peptides represent excellent scaffolds for design of novel anti-SARS-CoV-2 constrained peptides. Future studies should fully explore their antiviral mode of action as well as the structural dynamics of inhibition of target virus-host interactions.

Item Type:Article
Uncontrolled Keywords:Androctonus amoreuxi; SARS-CoV-2; COVID-19; Antimicrobial peptides; Scorpion venom peptides; Transcriptomic analysis; Spike protein - hACE2 interaction; Antiviral peptides
Group:Faculty of Science & Technology
ID Code:39421
Deposited By: Symplectic RT2
Deposited On:25 Jan 2024 10:45
Last Modified:25 Jan 2024 10:45


Downloads per month over past year

More statistics for this item...
Repository Staff Only -